IFNA1 and COVID-19: It has been reported that IFN signaling is suppressed by the nsp1, nsp6, nsp13, and ORF6 proteins of SARS-CoV-2 [8], and analysis of severe COVID-19 patients has shown that autoantibodies against IFNs are produced, which weakens their effect [9,10].